Peptide questions · Tesofensine

Tesofensine side effects: what studies and users report

Reviewed Evidence: ModeratePublished by PepVault

The side effects most commonly reported for tesofensine are dry mouth, insomnia and nausea, among 6 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: Not approved by the FDA or any other regulator; in Mexico the developer's partner has applied for approval, a technical committee gave a favorable opinion in February 2023, and as of November 2024 no approval had been granted.

What is commonly reported with tesofensine

  • Dry mouth
  • Insomnia
  • Nausea
  • Constipation or hard stools
  • Diarrhea
  • Faster heart rate

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for
EffectAlso listed for (of 28)
Dry mouth1: VK2735
InsomniaNone: listed for Tesofensine alone
Nausea24: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 20 more
Constipation or hard stoolsNone: listed for Tesofensine alone
Diarrhea23: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 19 more
Faster heart rateNone: listed for Tesofensine alone
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track tesofensine in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which tesofensine side effects the metabolic & GLP-1 group shares

Across the 29 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (25 of 29), diarrhea (24 of 29), vomiting (21 of 29) and constipation (15 of 29). Tesofensine shares 3 of its 6 listed effects with at least one other metabolic & GLP-1 compound; insomnia, constipation or hard stools and faster heart rate are listed for tesofensine alone.

What the tesofensine safety notes say

The library’s safety note

Not approved by the FDA or any other regulator; in Mexico the developer's partner has applied for approval, a technical committee gave a favorable opinion in February 2023, and as of November 2024 no approval had been granted. Its human safety record is phase 2 trials of up to about a year. In the main obesity trial the most common side effects were dry mouth, nausea, constipation, hard stools, diarrhea and insomnia; at 0.25 and 0.5 mg blood pressure did not rise against placebo, but heart rate rose by 7.4 beats a minute at 0.5 mg, and heart rate climbed with dose in the Parkinson's and Alzheimer's trials too. In 2013 The Lancet published an expression of concern about that trial's paper, and its authors published a letter on under-reporting of its adverse effects. In a study in recreational stimulant users its abuse potential was no greater than bupropion's. It lingers: its half-life is about ten days, so side effects take weeks to clear after stopping. Banned in competition in sport (WADA 2026, S6.B stimulants). Discuss with your clinician.

The library’s interaction note

Interaction data in people are limited. It raises noradrenaline, dopamine and serotonin, so other drugs acting on those messengers (antidepressants, stimulants, MAO inhibitors) are the class worth raising with a clinician; the developer paired it with metoprolol, a beta-blocker, to blunt the heart-rate rise. Exposure was 62% higher in women with reduced kidney function. Discuss any prescription medications with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Where the tesofensine reports come from

The library rates the evidence on tesofensine as moderate: animal studies plus some human data.

Of the library’s 5 research notes on tesofensine, 4 rest on randomized trials and 1 on community reports.

So tesofensine has controlled trials in people to set its listed effects against.

Questions people ask

What are the side effects of tesofensine?

The side effects most commonly reported for tesofensine are dry mouth, insomnia and nausea, among 6 the library lists; the library’s evidence on it includes controlled trials in people.

Do tesofensine’s side effects come from human studies?

The library rates the evidence on tesofensine as moderate, and the library’s evidence on it includes controlled trials in people.

Which tesofensine side effects are its own?

Among the metabolic & GLP-1 compounds, the library lists insomnia, constipation or hard stools and faster heart rate for tesofensine alone.

Does tesofensine interact with other medicines?

The library’s interaction note on tesofensine begins: Interaction data in people are limited.

More on tesofensine

Track it in the app

PepVault for iPhone

Track tesofensine in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo